1,169
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Relationship between triglyceride-glucose index and new-onset hypertension in general population–a systemic review and meta-analysis of cohort studies

, & ORCID Icon
Article: 2341631 | Received 20 Nov 2023, Accepted 05 Apr 2024, Published online: 14 Apr 2024

References

  • Mancia Chairperson G, Kreutz Co-Chair R, Brunström M, Januszewicz, A, Muiesan, ML, Tsioufis, K, Agabiti-Rosei, E, Algharably, EAE, Azizi, M, Benetos, A, et al. ESH Guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023;41:1874–9. PubMed: 37345492.
  • Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, Gregg EW, Bennett JE, Solomon B, Singleton RK. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80. doi: 10.1016/S0140-6736(21)01330-1. PubMed: 34450083.
  • Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, Brauer M, Burnett R, Cercy K, Charlson FJ, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016:388(10053);1659–724. 10.1016/S0140-6736(16)31679-8. PubMed: 27733284.
  • Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, Grassi G, Jordan J, Poulter NR, Rodgers A, et al. Hypertension. Nat Rev Dis Primers. 2018;4(1):18014. doi:10.1038/nrdp.2018.14. PubMed: 29565029.
  • Chowdhury M, Naeem I, Quan H, Leung AA, Sikdar KC, O’Beirne M, Turin TC. Prediction of hypertension using traditional regression and machine learning models: a systematic review and meta-analysis. PLoS One. 2022;17(4):e0266334. doi: 10.1371/journal.pone.0266334. PubMed: 35390039.
  • da Silva AA, Do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671–82. doi: 10.1016/j.cjca.2020.02.066. PubMed: 32389340.
  • Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216. doi: 10.1038/s41392-022-01073-0. PubMed: 35794109.
  • Minh HV, Tien HA, Sinh CT, Thang DC, Chen C-H, Tay JC, Siddique S, Wang T-D, Sogunuru GP, Chia Y-C, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens. 2021;23(3):529–37. doi:10.1111/jch.14155. PubMed: 33415834.
  • Khan SH, Sobia F, Niazi NK, Manzoor SM, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10(1):74. doi: 10.1186/s13098-018-0376-8. PubMed: 30323862.
  • Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, Jacques-Camarena O, Rodriíguez-Morán M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51. doi: 10.1210/jc.2010-0288. PubMed: 20484475.
  • Ding X, Wang X, Wu J, Zhang M, Cui M. Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76. doi: 10.1186/s12933-021-01268-9. PubMed: 33812373.
  • Wang Y, Yang W, Jiang X. Association between triglyceride-glucose index and hypertension: a meta-analysis. Front Cardiovasc Med. 2021;8:644035. doi:10.3389/fcvm.2021.644035. PubMed: 34136539.
  • Gao Q, Lin Y, Xu R, Luo F, Chen R, Li P, Zhang Y, Liu J, Deng Z, Li Y, et al. Positive association of triglyceride-glucose index with new-onset hypertension among adults: a national cohort study in China. Cardiovasc Diabetol. 2023;22(1):58. doi:10.1186/s12933-023-01795-7. PubMed: 36927705.
  • Sánchez-Íñigo L, Navarro-González D, Pastrana-Delgado J, Fernández-Montero A, Martínez JA. Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort. J Hypertens. 2016;34(7):1257–65. doi: 10.1097/HJH.0000000000000941. PubMed: 27136314.
  • Zhang J, Wang R, Liu Q, Song G, Tang X. Association of triglyceride-glucose index with incident hypertension among non-overweight healthy adults: a cohort study in China. Nutr Metab Cardiovasc Dis. 2023;33(5):1057–65. doi: 10.1016/j.numecd.2023.02.014. PubMed: 36948935.
  • Zhao Y, Yang X, Wu Y, Huang H, Hu F, Zhang M, Sun L, Hu D. Association of triglyceride–glucose index and its 6-year change with risk of hypertension: a prospective cohort study. Nutr Metab Cardiovasc Dis. 2023;33(3):568–76. doi: 10.1016/j.numecd.2022.12.001. PubMed: 36642606.
  • Zheng R, Mao Y. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis. 2017;16(1):175. doi: 10.1186/s12944-017-0562-y. PubMed: 28903774.
  • Liu T, Xuan H, Yin J, Wang L, Wang C, Xu X, Chen J, Li D, Xu T. Triglyceride glucose index increases significantly risk of hypertension development in Chinese individuals aged ≥45 years old: analysis from the China health and retirement longitudinal study. J Multidiscip Healthc. 2023;16:63–73. doi:10.2147/JMDH.S391905. PubMed: 36660037.
  • Khoo JK, Low S, Irwan B, Tang J, Sum CF, Subramaniam T, Lim SC. The role of triglyceride-glucose index in the prediction of the development of hypertension - findings from a community cohort in singapore. J ASEAN Fed Endocr Soc. 2023;38(1):62–67. doi: 10.15605/jafes.038.01.09. PubMed: 37252412.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097. PubMed: 19621072.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–05. doi: 10.1007/s10654-010-9491-z. PubMed: 20652370.
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi: 10.1136/bmj.327.7414.557. PubMed: 12958120.
  • Duval S, Tweedie R. Trim and fill: a simple funnel-plot–based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–63. doi: 10.1111/j.0006-341X.2000.00455.x. PubMed: 10877304.
  • Serné EH, Ijzerman RG, de Jongh RT, Stehouwer CD. Blood pressure and insulin resistance: role for microvascular function?. Cardiovasc Res. 2002;55(2):418–19. doi: 10.1016/S0008-6363(02)00436-4. disscusion 420-1 PubMed: 12123783.
  • Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766. doi:10.1016/j.metabol.2021.154766. PubMed: 33766485.
  • Boutouyrie P, Chowienczyk P, Humphrey JD, Mitchell GF. Arterial stiffness and cardiovascular risk in hypertension. Circ Res. 2021;128(7):864–86. doi: 10.1161/CIRCRESAHA.121.318061. PubMed: 33793325.
  • Jia G, Sowers JR. Hypertension in diabetes: an update of basic mechanisms and clinical disease. Hypertension. 2021;78(5):1197–205. doi: 10.1161/HYPERTENSIONAHA.121.17981. PubMed: 34601960.
  • Wu S, Xu L, Wu M, Chen S, Wang Y, Tian Y. Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study. Cardiovasc Diabetol. 2021;20(1):146. doi: 10.1186/s12933-021-01342-2. PubMed: 34271940.
  • Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018;15(2):97–105. doi: 10.1038/nrcardio.2017.155. PubMed: 29022570.